A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19
Clinical trial NCT04487210 · COMPLETED
Trial details
- NCT number
- NCT04487210
- Sponsor
- Medigen Vaccine Biologics Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2021-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.